(Q64390384)
Statements
Targeting components of the alternative NHEJ pathway sensitizes KRAS mutant leukemic cells to chemotherapy (English)
Patricia S Hähnel
Birgit Enders
Daniel Sasca
Bernd Kaina
Lars Bullinger
Matthias Theobald
scientific article published on 06 February 2014